Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-023533
Filing Date
2021-06-14
Accepted
2021-06-14 16:05:23
Documents
1
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4396
  Complete submission text file 0000899243-21-023533.txt   5772
Mailing Address CRITICAL THERAPEUTICS INC 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address
George Jean (Reporting) CIK: 0001291804 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 211014624

Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations